4/2
Perelman School of Medicine
Out-of-pocket cost increase could put HIV prevention medications out of reach
A Penn Medicine study finds that even modest increases in out-of-pocket costs for HIV prevention drugs could double the rate at which prescriptions go unfilled.
New AI tool brings precision pathology for cancer into quicker, sharper focus
Researchers at Penn Medicine have developed an artificial intelligence tool to quickly analyze gene activities in medical images and provide single-cell insight into diseases in tissues and tissue microenvironments.
How Penn Medicine is changing the world with mRNA
Vaccines are just the beginning of the potential for messenger RNA, the Nobel Prize-winning technology.
New treatment reverses Alzheimer’s disease signs
According to a preclinical study from Penn Medicine researchers, a molecular compound mimics the effect of natural chaperones that are depleted in the aging brain.
Penn Medicine sets a worldwide record with 100 kidney paired donation transplants in a year
The Penn Transplant Institute coordinates with the National Kidney Register to help pair the more than 90,000 patients on the waitlist with a deceased donor.
Research shows how stress activates neurons that disrupt sleep
New research from Penn Medicine shows suppressing these neurons may be a promising target for therapies to treat stress-related sleep disorders, like insomnia and PTSD.
First in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses
The therapy tested in a Phase 1 clinical trial might drastically change the way the T cells work, potentially allowing the new CAR T cell product to work where other products have failed.
One in six patients with opioid use disorder leaving the hospital before completing treatment
A new Penn Medicine analysis shows that discharges too early for patients with opioid use disorder increased over 50% between 2016 and 2020.
Could a single shot heal heart disease?
Experts at Penn Medicine are researching novel treatments for heart disease, including CRISPR gene editing technology, CAR T technology, and mRNA injections.
Lidocaine may be able to kill certain cancer cells by activating bitter taste receptors
A preclinical Penn Medicine study explains the previously observed anti-cancer effect of the common anesthetic drug.
In the News
Scholars at risk in their own countries find a new home at Penn
Penn Global’s Scholars-at-Risk program is featured. Global’s Ezekiel J. Emanuel and Scott Moore, Penn Carey Law’s Eric Feldman, and Wharton’s Jesús Fernández-Villaverde, along with former and current scholars Angel Alvarado, Pavel Golubev, and Jawad Moradi are interviewed.
FULL STORY →
Sugar-coated gold nanoparticles could replace some antibiotics
According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.
FULL STORY →
Alzheimer’s may be caused by a build-up of fat in brain cells
A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.
FULL STORY →
A new strategy to attack aggressive brain cancer shrank tumors in two early tests
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
FULL STORY →
Philadelphia hospital program adds psychologists to bridge mental health services for trauma survivors
A new psychology team at the Penn Trauma Violence Recovery Program has provided about 46 survivors with short- and long- term therapy, featuring remarks from Elinore Kaufman and Lily Brown of the Perelman School of Medicine.
FULL STORY →